Access
To read this story in full you will need to login or make a payment (see right).
Insight
Nature 441, 1094-1096 (29 June 2006) | doi:10.1038/nature04960; Published online 28 June 2006
Open Innovation Challenges
-
Efficient Chromosome Doubling: Plant Cell Division
The Seeker is looking for an efficient chromosome doubling method in plants and in particular, metho...
-
Protect Enzyme from In Planta Degradation
A proposal for stable expression of an enzyme in corn seed is desired.
- More Challenges
- Powered by:
nature jobs
Postdoctoral Position, Endocrine Unit
- MGH-Harvard Medical School
- MGH, 50 Blossom Street, Boston MA 02114
2 Post-Doctoral Positions
- German Cancer Research Center
- Heidelberg 69120 Germany
Progress Stem cells for the treatment of neurological disorders
Olle Lindvall1,3 & Zaal Kokaia2,3
Abstract
Many common neurological disorders, such as Parkinson's disease, stroke and multiple sclerosis, are caused by a loss of neurons and glial cells. In recent years, neurons and glia have been generated successfully from stem cells in culture, fuelling efforts to develop stem-cell-based transplantation therapies for human patients. More recently, efforts have been extended to stimulating the formation and preventing the death of neurons and glial cells produced by endogenous stem cells within the adult central nervous system. The next step is to translate these exciting advances from the laboratory into clinically useful therapies.
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
NEWS AND VIEWS
Neural stem cells, scaffolds, and chaperonesNature Biotechnology Research News (01 Nov 2002)
Neurotrophic factor therapy ? Keeping scoreNature Medicine News and Views (01 May 1997)
See all 5 matches for News And Views